Back to
RENAISSANCE TECHNOLOGIES LLC
HBIO2 quarters
Position history for
RENAISSANCE TECHNOLOGIES LLC's holdings in HARVARD BIOSCIENCE INC
Yes. Renaissance Technologies holds 99,327 shares of HBIO (Harvard Bioscience), worth $610,861, as of its Q2 2026 13F filing. It reduced the position by 2,100 shares (-2.1%) from Q1 2026. Renaissance Technologies has held HBIO since Q1 2026, across 2 quarterly 13F filings.
Current Value
$610,861
Current Shares
99,327
Total Value Change
+$116,912
Total Shares Change
-2,100
Quarter-by-Quarter History
Other major holders of HBIO: VANGUARD CAPITAL MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP, BlackRock, Inc.